All Pharma News
Ajinomoto To Lay Off 71 In CA After $620M Forge Biologics Acquisition

Ajinomoto To Lay Off 71 In CA After $620M Forge Biologics Acquisition
FIERCE PHARMA
12 Aug 2024
Share Share
Forge Announces 9 Presentations At ASGCT Annual Meeting

Forge Announces 9 Presentations At ASGCT Annual Meeting
BUSINESSWIRE
30 Apr 2024
Share Share
Forge Biologics’ Novel AAV Gene Therapy FBX-101 for Patients with Krabbe Disease

Forge Biologics’ Novel AAV Gene Therapy FBX-101 for Patients with Krabbe Disease
BUSINESSWIRE
19 Mar 2024
Share Share
Forge’s AAV Gene Therapy Granted Innovation Passport Designation Krabbe Disease

Forge’s AAV Gene Therapy Granted Innovation Passport Designation Krabbe Disease
CONTRACT PHARMA
19 Mar 2024
Share Share
Forge Biologics Announces Positive FBX-101 Clinical Trial Update

Forge Biologics Announces Positive FBX-101 Clinical Trial Update
BUSINESSWIRE
29 Jan 2024
Share Share
Forge Biologics Announces Publication in Human Gene Therapy

Forge Biologics Announces Publication in Human Gene Therapy
BUSINESSWIRE
12 Dec 2023
Share Share
New acquisition to support global gene therapy manufacturing

New acquisition to support global gene therapy manufacturing
EUROPEAN PHARMACEUTICAL REVIEW
15 Nov 2023
Share Share
CDMO Ajinomoto forges ahead with Forge Biologics in $620M acquisition

CDMO Ajinomoto forges ahead with Forge Biologics in $620M acquisition
FIERCE PHARMA
13 Nov 2023
Share Share
Forge blazes into collaboration to bolster AAV gene therapies

Forge blazes into collaboration to bolster AAV gene therapies
Joseph Keenan FIERCE PHARMA
12 Oct 2023
Share Share
Forge Biologics Selected as AAV Manufacturing Partner for California Institute

Forge Biologics Selected as AAV Manufacturing Partner for California Institute
BUSINESSWIRE
11 Oct 2023
Share Share